Multi-omic biomarker discovery and network analyses to elucidate the molecular mechanisms of lung cancer premalignancy
Lung cancer (LC) is the leading cause of cancer death in the US, claiming over 160,000 lives annually. Although CT screening has been shown to be efficacious in reducing mortality, the limited access to screening programs among high-risk individuals and the high number of false positives contribute...
Main Author: | Tassinari, Anna |
---|---|
Language: | en_US |
Published: |
2018
|
Subjects: | |
Online Access: | https://hdl.handle.net/2144/27344 |
Similar Items
-
Multi-omics data integration for the detection and characterization of smoking related lung diseases
by: Pavel, Ana Brandusa
Published: (2017) -
Metabolomic and Lipidomic Biomarkers for Premalignant Liver Disease Diagnosis and Therapy
by: Diren Beyoğlu, et al.
Published: (2020-01-01) -
Expression of CD133 in various premalignant and proliferative lesions
by: Rahmi Amtha, et al.
Published: (2015-06-01) -
Immunological and classical subtypes of oral premalignant lesions
by: Jean-Philippe Foy, et al.
Published: (2018-12-01) -
Autofluorescence and diffuse reflectance spectroscopic analysis of oral premalignancy and malignancy
by: S Jayachandran, et al.
Published: (2009-01-01)